BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 197,100 shares, a growth of 164.6% from the November 30th total of 74,500 shares. Based on an average daily volume of 602,900 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.7% of the company’s shares are short sold.
BioNexus Gene Lab Stock Performance
BioNexus Gene Lab stock opened at $0.24 on Friday. BioNexus Gene Lab has a 52-week low of $0.21 and a 52-week high of $3.39. The firm has a 50 day moving average price of $0.31 and a two-hundred day moving average price of $0.40.
About BioNexus Gene Lab
Featured Stories
- Five stocks we like better than BioNexus Gene Lab
- What is a Special Dividend?
- Top 3 Investment Themes to Watch for in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How is Compound Interest Calculated?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.